Northwire Canada EditionFriday, October 23, 2026
Northwire
⌕
GOLD 4060.40 −2.2% SILVER 55.01 −4.7% COPPER 6.40 −2.8% OIL 99.47 +2.4% PALLADIUM 1052.50 −3.4% ATY 0.215 −8.5% CNL 14.70 −8.9% ABI 0.060 +0.0% AUGC 0.245 −12.5% ITR 3.18 −5.4% LKY 0.005 +0.0% IGO 0.125 +0.0% CCMM 0.390 −9.3% FVI 13.33 −8.1% KTN 0.840 −10.6% FTUR 0.240 −14.3% YARR 0.150 +0.0% EMNT 0.290 −14.7% MOO 0.680 +13.3% BMM 4.27 −0.7% GOLD 4060.40 −2.2% SILVER 55.01 −4.7% COPPER 6.40 −2.8% OIL 99.47 +2.4% PALLADIUM 1052.50 −3.4% ATY 0.215 −8.5% CNL 14.70 −8.9% ABI 0.060 +0.0% AUGC 0.245 −12.5% ITR 3.18 −5.4% LKY 0.005 +0.0% IGO 0.125 +0.0% CCMM 0.390 −9.3% FVI 13.33 −8.1% KTN 0.840 −10.6% FTUR 0.240 −14.3% YARR 0.150 +0.0% EMNT 0.290 −14.7% MOO 0.680 +13.3% BMM 4.27 −0.7%
Other

SuperQ Quantum Enters Commercial Agreement to Deploy Quantum-AI Clinician Systems for Science & Humans

QBTQ · Price

Executive Summary

  • SuperQ Quantum Computing Inc. entered into a commercial agreement with Science & Humans (S&H) to develop and deploy quantum‑AI powered clinician solutions for S&H’s hormonal health services.
  • The collaboration leverages SuperQ’s Super™ platform, integrating quantum computing, AI orchestration, and classical high‑performance compute to create autonomous diagnostic and treatment tools.
  • Both companies highlight the partnership as a milestone toward full production of the solution in the coming months, positioning the technology for broader healthcare applications.

Key Details

  • Agreement Scope: SuperQ will architect, build, and deliver quantum‑AI clinician systems for S&H, covering patient triage, diagnostic decision‑support, prescription workflow automation, chronic disease management, real‑time monitoring, and healthcare logistics.
  • Technology Stack: Utilizes Super™ platform’s “gateway” architecture to interoperate across quantum hardware types (annealing, gate‑based, hybrid) with GPU‑based AI pipelines and classical compute resources.
  • Project Status: Minimum Viable Product (MVP) already achieved; full production rollout planned in the coming months.
  • Strategic Context: Announcement coincides with NVIDIA’s NVQLink interconnect launch, underscoring industry movement toward hybrid quantum‑classical infrastructures.
  • Company Highlights:
  • S&H ranked #32 on Deloitte Canada’s 2025 Technology Fast 50 (970% growth over three years).
  • SuperQ recently expanded its hardware‑software roadmap, launching the Super™ hybrid platform and initiating quantum‑hardware development.
  • Leadership Comments:
  • Aftab Pashaw, CEO of S&H – expressed excitement about pioneering quantum‑AI in clinical workflows and noted achievement of MVP stage.
  • Dr. Muhammad Khan, CEO & Board Chair of SuperQ – emphasized growing commercial demand for the Super™ platform and its readiness to transform clinician workflows.

Notable Quotes

  • “We are excited to be the first to explore frontier AI and quantum technologies in clinical diagnosis and treatment.” – Aftab Pashaw, CEO, Science & Humans
  • “The Science & Humans project signals that quantum‑AI is now ready to transform clinician workflows, where the margin for error is minimal and the stakes are highest.” – Dr. Muhammad Khan, CEO & Board Chair, SuperQ Quantum Computing Inc.
Read the original news release →

More from SuperQ Quantum Computing Inc.